MRI Interventions’ ClearPoint® Neuro-Navigation

IRVINE, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint ^® Neuro Navigation System will be featured as the One Room-One Procedure laser fiber placement technique at the Practical Clinic entitled “Laser Ablation Surgery: Opportunities, Indications, Technique and Outcomes” during the Congress of Neurological Surgeons (CNS) taking place on October 7 - 11, 2017, in Boston, Massachusetts. Surgeons will be able to evaluate workflows for patient safety and comfort including frameless, minimally invasive techniques for laser ablation performed entirely in the MRI suite. 

“We continue to see strong adoption of the ClearPoint Neuro Navigation System among leading functional neurosurgical centers across the country.  Due to the precision and accuracy provided by real-time MRI guidance and visualization this is a persuasive option for surgeons and their patients," stated Frank Grillo, Chief Executive Officer for MRI Interventions.  “The ClearPoint System allows surgeons to plan, target, and adjust for multiple trajectories resulting in highly accurate laser ablation of amorphic target lesions. In addition, patients under general anesthesia do not have to endure the placement of a large stereotactic headframe for placement of the laser fiber, which improves patient comfort.” 

Following the Practical Clinic, CNS attendees are invited to visit the MRI Interventions booth (#904) to learn about the ClearPoint Neuro Navigation System.  ClearPoint goes beyond planning, enabling surgeons to perform a wide range of minimally-invasive neurosurgical procedures under real-time MRI visualization.

About MRI Interventions, Inc.

Building on the imaging power of magnetic resonance imaging (“MRI”), MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain.  The ClearPoint Neuro Navigation System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com .

Forward-Looking Statements

Statements herein concerning MRI Interventions, Inc. (the “Company”) plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the Company's actual results to differ materially from those expressed in or implied by forward-looking statements.  Particular uncertainties and risks include those relating to: future revenues from sales of the Company’s ClearPoint Neuro Navigation System products; and the Company’s ability to market, commercialize and achieve broader market acceptance for the Company’s ClearPoint Neuro Navigation System products.  More detailed information on these and additional factors that could affect the Company’s actual results are described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, and the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2017, both of which have been filed with the Securities and Exchange Commission.

Wendelin Maners, VP, Sales and Marketing MRI Interventions, Inc. 949-900-6833

For Investors: Matt Kreps, Darrow Associates Investor Relations (512) 696-6401 mkreps@darrowir.com